Who Paid My Doc
Vizamyl
Drug Core Imaging
NDC 17156-067-10
General payments
$0
Research payments
$163,849
Through program year 2023, $0 in general payments and $163,849 in research payments were reported against Vizamyl (Core Imaging).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $95,540 | 3 |
| 2022 | Research | $68,309 | 1 |
Records
4 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.